Unresolved disorder model. using A ATOM 63 CA AVAL 10 -2.455 -7.073 -25.319 1.00 14.37 C Unresolved disorder model. using A ATOM 66 CB AVAL 10 -3.787 -7.523 -26.006 1.00 17.89 C Unresolved disorder model. using A ATOM 67 CG1AVAL 10 -3.781 -7.270 -27.515 1.00 17.68 C Unresolved disorder model. using A ATOM 68 CG2AVAL 10 -4.066 -9.000 -25.704 1.00 17.59 C Unresolved disorder model. using A ATOM 103 N AGLY 15 -1.698 0.946 -18.948 1.00 19.29 N Unresolved disorder model. using A ATOM 104 CA AGLY 15 -2.642 1.790 -18.232 1.00 21.66 C Unresolved disorder model. using A ATOM 105 C AGLY 15 -3.556 2.631 -19.101 1.00 29.93 C Unresolved disorder model. using A ATOM 106 O AGLY 15 -3.347 2.750 -20.311 1.00 27.83 O Unresolved disorder model. using A ATOM 107 N AMET 16 -4.591 3.203 -18.455 1.00 31.13 N Unresolved disorder model. using A ATOM 108 CA AMET 16 -5.633 4.061 -19.032 1.00 33.29 C Unresolved disorder model. using A ATOM 109 C AMET 16 -6.138 4.966 -17.894 1.00 40.88 C Unresolved disorder model. using A ATOM 110 O AMET 16 -6.423 4.462 -16.804 1.00 39.93 O Unresolved disorder model. using A ATOM 111 CB AMET 16 -6.789 3.191 -19.599 1.00 35.98 C Unresolved disorder model. using A ATOM 112 CG AMET 16 -7.850 3.967 -20.380 1.00 39.93 C Unresolved disorder model. using A ATOM 113 SD AMET 16 -7.233 4.707 -21.915 1.00 44.44 S Unresolved disorder model. using A ATOM 114 CE AMET 16 -8.779 5.057 -22.762 1.00 41.29 C Unresolved disorder model. using A ATOM 115 N AGLU 17 -6.214 6.295 -18.141 1.00 40.88 N Unresolved disorder model. using A ATOM 116 CA AGLU 17 -6.675 7.323 -17.185 1.00 42.33 C Unresolved disorder model. using A ATOM 117 C AGLU 17 -6.129 7.131 -15.745 1.00 47.98 C Unresolved disorder model. using A ATOM 118 O AGLU 17 -6.881 7.196 -14.759 1.00 47.67 O Unresolved disorder model. using A ATOM 119 CB AGLU 17 -8.211 7.457 -17.223 1.00 44.00 C Unresolved disorder model. using A ATOM 120 CG AGLU 17 -8.719 8.289 -18.388 1.00 57.83 C Unresolved disorder model. using A ATOM 121 CD AGLU 17 -8.813 7.556 -19.709 1.00 86.52 C Unresolved disorder model. using A ATOM 122 OE1AGLU 17 -9.750 6.740 -19.869 1.00 91.66 O Unresolved disorder model. using A ATOM 123 OE2AGLU 17 -7.962 7.810 -20.593 1.00 79.25 O Unresolved disorder model. using A ATOM 124 N AASN 18 -4.803 6.872 -15.660 1.00 45.09 N Unresolved disorder model. using A ATOM 125 CA AASN 18 -4.025 6.613 -14.443 1.00 45.27 C Unresolved disorder model. using A ATOM 126 C AASN 18 -4.590 5.544 -13.485 1.00 48.47 C Unresolved disorder model. using A ATOM 127 O AASN 18 -4.776 5.790 -12.286 1.00 48.26 O Unresolved disorder model. using A ATOM 128 CB AASN 18 -3.550 7.899 -13.750 1.00 46.77 C Unresolved disorder model. using A ATOM 129 CG AASN 18 -2.050 8.042 -13.807 1.00 70.35 C Unresolved disorder model. using A ATOM 130 OD1AASN 18 -1.299 7.381 -13.071 1.00 66.00 O Unresolved disorder model. using A ATOM 131 ND2AASN 18 -1.580 8.882 -14.710 1.00 60.36 N Unresolved disorder model. using A ATOM 132 N AALA 19 -4.863 4.351 -14.049 1.00 44.31 N Unresolved disorder model. using A ATOM 133 CA AALA 19 -5.382 3.154 -13.363 1.00 43.60 C Unresolved disorder model. using A ATOM 134 C AALA 19 -5.167 1.903 -14.241 1.00 45.46 C Unresolved disorder model. using A ATOM 135 O AALA 19 -5.134 2.017 -15.469 1.00 43.51 O Unresolved disorder model. using A ATOM 136 CB AALA 19 -6.871 3.318 -13.061 1.00 44.04 C Unresolved disorder model. using A ATOM 137 N AMET 20 -5.011 0.725 -13.608 1.00 42.40 N Unresolved disorder model. using A ATOM 138 CA AMET 20 -4.888 -0.558 -14.314 1.00 42.75 C Unresolved disorder model. using A ATOM 139 C AMET 20 -6.329 -1.082 -14.471 1.00 45.93 C Unresolved disorder model. using A ATOM 140 O AMET 20 -7.009 -1.242 -13.450 1.00 46.32 O Unresolved disorder model. using A ATOM 141 CB AMET 20 -4.025 -1.569 -13.527 1.00 45.14 C Unresolved disorder model. using A ATOM 142 CG AMET 20 -2.534 -1.315 -13.633 1.00 49.30 C Unresolved disorder model. using A ATOM 143 SD AMET 20 -1.548 -2.481 -12.648 1.00 53.98 S Unresolved disorder model. using A ATOM 144 CE AMET 20 -2.000 -1.949 -10.982 1.00 50.88 C Unresolved disorder model. using A ATOM 145 N APRO 21 -6.842 -1.294 -15.711 1.00 40.76 N Unresolved disorder model. using A ATOM 146 CA APRO 21 -8.245 -1.733 -15.862 1.00 39.93 C Unresolved disorder model. using A ATOM 147 C APRO 21 -8.585 -3.066 -15.179 1.00 41.44 C Unresolved disorder model. using A ATOM 148 O APRO 21 -9.430 -3.087 -14.275 1.00 41.57 O Unresolved disorder model. using A ATOM 149 CB APRO 21 -8.456 -1.763 -17.385 1.00 41.76 C Unresolved disorder model. using A ATOM 150 CG APRO 21 -7.358 -0.939 -17.954 1.00 46.11 C Unresolved disorder model. using A ATOM 151 CD APRO 21 -6.196 -1.115 -17.028 1.00 41.99 C Unresolved disorder model. using A ATOM 740 CA AARG 98 7.690 7.611 -19.460 0.50 13.29 C Unresolved disorder model. using A ATOM 741 CA BARG 98 7.720 7.538 -19.507 0.50 13.57 C Unresolved disorder model. using A ATOM 744 CB AARG 98 7.362 9.094 -19.136 0.50 13.35 C Unresolved disorder model. using A ATOM 745 CB BARG 98 7.470 9.062 -19.534 0.50 15.35 C Unresolved disorder model. using A ATOM 746 CG AARG 98 8.355 10.082 -19.775 0.50 24.52 C Unresolved disorder model. using A ATOM 747 CG BARG 98 6.244 9.555 -18.794 0.50 26.12 C Unresolved disorder model. using A ATOM 748 CD AARG 98 8.520 11.391 -19.013 0.50 19.62 C Unresolved disorder model. using A ATOM 749 CD BARG 98 5.414 10.462 -19.676 0.50 32.61 C Unresolved disorder model. using A ATOM 750 NE AARG 98 9.852 11.974 -19.218 0.50 11.03 N Unresolved disorder model. using A ATOM 751 NE BARG 98 5.939 11.825 -19.648 0.50 37.81 N Unresolved disorder model. using A ATOM 752 CZ AARG 98 10.287 13.086 -18.629 0.50 19.08 C Unresolved disorder model. using A ATOM 753 CZ BARG 98 5.387 12.824 -18.972 0.50 43.95 C Unresolved disorder model. using A ATOM 754 NH1AARG 98 9.495 13.768 -17.811 0.50 8.92 N Unresolved disorder model. using A ATOM 755 NH1BARG 98 4.258 12.636 -18.299 0.50 31.07 N Unresolved disorder model. using A ATOM 756 NH2AARG 98 11.518 13.523 -18.852 0.50 6.97 N Unresolved disorder model. using A ATOM 757 NH2BARG 98 5.947 14.026 -18.978 0.50 23.91 N Unresolved disorder model. using A ATOM 844 N ALYS 109 17.344 -6.368 -15.955 0.50 9.32 N Unresolved disorder model. using A ATOM 845 N BLYS 109 17.344 -6.363 -15.960 0.50 9.47 N Unresolved disorder model. using A ATOM 846 CA ALYS 109 16.290 -7.343 -15.700 0.50 8.40 C Unresolved disorder model. using A ATOM 847 CA BLYS 109 16.279 -7.329 -15.732 0.50 8.64 C Unresolved disorder model. using A ATOM 848 C ALYS 109 14.904 -6.713 -15.910 0.50 11.76 C Unresolved disorder model. using A ATOM 849 C BLYS 109 14.907 -6.696 -15.956 0.50 11.88 C Unresolved disorder model. using A ATOM 850 O ALYS 109 14.727 -5.521 -15.658 0.50 10.09 O Unresolved disorder model. using A ATOM 851 O BLYS 109 14.734 -5.495 -15.738 0.50 10.17 O Unresolved disorder model. using A ATOM 852 CB ALYS 109 16.454 -7.839 -14.246 0.50 9.09 C Unresolved disorder model. using A ATOM 853 CB BLYS 109 16.396 -7.861 -14.287 0.50 9.61 C Unresolved disorder model. using A ATOM 854 CG ALYS 109 15.948 -9.234 -13.951 0.50 12.42 C Unresolved disorder model. using A ATOM 855 CG BLYS 109 15.800 -9.242 -14.058 0.50 15.51 C Unresolved disorder model. using A ATOM 856 CD ALYS 109 16.501 -9.754 -12.608 0.50 9.80 C Unresolved disorder model. using A ATOM 857 CD BLYS 109 16.067 -9.804 -12.642 0.50 16.40 C Unresolved disorder model. using A ATOM 858 CE ALYS 109 15.798 -11.018 -12.173 0.50 11.11 C Unresolved disorder model. using A ATOM 859 CE BLYS 109 17.514 -10.145 -12.374 0.50 16.65 C Unresolved disorder model. using A ATOM 860 NZ ALYS 109 16.293 -11.564 -10.873 0.50 10.55 N Unresolved disorder model. using A ATOM 861 NZ BLYS 109 17.688 -10.964 -11.148 0.50 14.61 N 1